Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Critical Care
Volume 2014, Article ID 179313, 3 pages
http://dx.doi.org/10.1155/2014/179313
Case Report

Extreme Procalcitonin Elevation without Proven Bacterial Infection Related to Amphetamine Abuse

1Department of Anaesthesiology and Intensive Therapy, University of Szeged, Semmelweis Utca 6, Szeged 6722, Hungary
2Département d’Anesthésiologie, Hôpitaux Universitaires de Genève, 4 rue Gabrielle Perret-Gentil, 1211 Geneva 14, Switzerland

Received 29 December 2013; Accepted 11 February 2014; Published 11 March 2014

Academic Editors: M. Doganay, E. Kolho, P. Kopterides, and N. Nin

Copyright © 2014 András Lovas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Wacker, A. Prkno, F. M. Brunkhorst, and P. Schlattmann, “Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis,” The Lancet Infectious Diseases, vol. 13, no. 5, pp. 426–435, 2013. View at Google Scholar
  2. M. Hochreiter, T. Köhler, A. M. Schweiger et al., “Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial,” Critical Care, vol. 13, no. 3, article R83, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. G. A. Wanner, M. Keel, U. Steckholzer, W. Beier, R. Stocker, and W. Ertel, “Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients,” Critical Care Medicine, vol. 28, no. 4, pp. 950–957, 2000. View at Google Scholar · View at Scopus
  4. I. Sulyok, E. Fleischmann, A. Stift et al., “Effect of preoperative fever-range whole-body hyperthermia on immunological markers in patients undergoing colorectal cancer surgery,” British Journal of Anaesthesia, vol. 109, no. 5, pp. 754–761, 2012. View at Google Scholar
  5. M. Carvalho, H. Carmo, V. M. Costa et al., “Toxicity of amphetamines: an update,” Archives of Toxicology, vol. 86, no. 8, pp. 1167–1231, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Pfäfflin and E. Schleicher, “Inflammation markers in point-of-care testing (POCT),” Analytical and Bioanalytical Chemistry, vol. 393, no. 5, pp. 1473–1480, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. P. Hall and J. A. Henry, “Acute toxic effects of “Ecstasy” (MDMA) and related compounds: overview of pathophysiology and clinical management,” British Journal of Anaesthesia, vol. 96, no. 6, pp. 678–685, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Institóris, A. R. Tóth, A. Molnár et al., “The frequency of alcohol, illicit and licit drug consumption in the general driving population in South-East Hungary,” Forensic Science International, vol. 224, no. 1–3, pp. 37–43, 2013. View at Google Scholar
  9. M. A. Denborough and K. C. Hopkinson, “Dantrolene and ‘Ecstasy’,” The Medical Journal of Australia, vol. 166, no. 3, pp. 165–166, 1997. View at Google Scholar · View at Scopus
  10. K. L. Becker, R. Snider, and E. S. Nylen, “Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations,” Critical Care Medicine, vol. 36, no. 3, pp. 941–952, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. K. L. Becker, R. Snider, and E. S. Nylen, “Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target,” British Journal of Pharmacology, vol. 159, no. 2, pp. 253–264, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Level, P. Chauveau, O. Guisset et al., “Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure,” Critical Care, vol. 7, no. 6, pp. R160–R166, 2003. View at Google Scholar
  13. A. S. Jaffe, V. C. Vasile, M. Milone, A. K. Saenger, K. N. Olson, and F. S. Apple, “Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T,” Journal of the American College of Cardiology, vol. 58, no. 17, pp. 1819–1824, 2011. View at Publisher · View at Google Scholar · View at Scopus